Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
CN Stock MarketDetailed Quotes
China Resources Sanjiu Medical & Pharmaceutical (000999)
- 28.34
- +0.04+0.14%
Market Closed Jan 23 15:00 CST
47.16BMarket Cap17.08P/E (TTM)
28.59High28.30Low85.75KlotVolume28.39Open28.30Prev Close243.94MTurnover0.52%Turnover Ratio14.00P/E (Static)1.66BShares34.6752wk High2.23P/B47.12BFloat Cap27.2852wk Low31.13Limit Up1.66BShs Float38.96Historical High25.47Limit Down1.03%Range %-4.25Historical Low1.47Dividend TTM28.45Avg Price45.33KlotAsk5.17%Div Yield TTM100Lot Size37.54KlotBid
China Resources Sanjiu Medical & Pharmaceutical (000999) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 11.38%21.99B | 4.99%14.81B | -6.04%6.85B | 11.63%27.62B | 6.08%19.74B | 7.30%14.11B | 14.82%7.29B | 36.83%24.74B | 53.65%18.61B | 56.48%13.15B |
| Operating revenue | 11.38%21.99B | 4.99%14.81B | -6.04%6.85B | 11.63%27.62B | 6.08%19.74B | 7.30%14.11B | 14.82%7.29B | 36.83%24.74B | 53.65%18.61B | 56.48%13.15B |
| Other operating revenue | ---- | 36.78%510.13M | ---- | 27.65%1.15B | ---- | -32.65%372.96M | ---- | 34.95%901.47M | ---- | 51.43%553.78M |
| Total operating cost | 18.35%18.78B | 11.58%12.3B | -3.84%5.28B | 10.58%23.25B | 2.97%15.87B | 3.32%11.02B | 13.81%5.49B | 37.80%21.02B | 57.00%15.41B | 60.36%10.67B |
| Operating cost | 9.41%10.22B | 5.03%6.88B | -5.75%3.2B | 14.94%13.3B | 4.13%9.34B | 4.28%6.55B | 16.46%3.4B | 39.14%11.57B | 63.79%8.97B | 65.75%6.28B |
| Operating tax surcharges | 31.08%264.35M | 20.77%181.14M | 3.85%78.14M | 7.23%294.78M | 4.05%201.67M | 10.37%149.98M | 14.18%75.25M | 32.77%274.91M | 46.96%193.82M | 50.55%135.89M |
| Operating expense | 28.98%6.13B | 18.94%3.94B | -4.05%1.5B | 3.66%7.22B | -0.34%4.75B | 0.69%3.31B | 11.26%1.56B | 37.21%6.97B | 48.90%4.77B | 52.75%3.29B |
| Administration expense | 21.53%1.3B | 17.41%829.2M | 3.77%351.44M | 8.81%1.66B | 3.26%1.07B | 4.25%706.27M | 9.57%338.68M | 43.92%1.52B | 56.99%1.04B | 55.50%677.45M |
| Financial expense | 253.10%20.4M | 129.86%7.37M | 106.31%1.49M | 0.00%-24.19M | 35.06%-13.33M | -87.10%-24.67M | -223.79%-23.66M | -539.25%-24.19M | -91.99%-20.52M | 59.86%-13.19M |
| -Interest expense (Financial expense) | 25.06%81.86M | 14.95%49.57M | 4.11%21.68M | -0.92%80.04M | 25.19%65.46M | 59.47%43.12M | 114.47%20.82M | 280.56%80.78M | 266.28%52.29M | 233.48%27.04M |
| -Interest Income (Financial expense) | 20.53%-65.41M | 35.73%-44.1M | 52.32%-21.99M | 3.82%-102.78M | -13.13%-82.31M | -73.62%-68.61M | -201.37%-46.12M | -45.43%-106.86M | -44.37%-72.75M | -7.36%-39.52M |
| Research and development | 64.07%840.33M | 40.61%459.04M | 5.15%144.5M | 12.21%801.75M | 11.72%512.18M | 10.59%326.46M | 3.64%137.42M | 20.30%714.5M | 29.95%458.44M | 37.30%295.21M |
| Credit Impairment Loss | 53.37%-46.77M | 62.49%-27.09M | 104.49%1.72M | -38.77%-94.05M | -134.98%-100.3M | -23.97%-72.23M | -19.89%-38.23M | -1,034.45%-67.78M | -42.63%-42.68M | -117.53%-58.27M |
| Asset Impairment Loss | 30.39%-77.2M | -104.97%-51.63M | 139.36%8.08M | 5.42%-163.29M | -42.05%-110.9M | -40.73%-25.19M | 12.92%-20.54M | -24.85%-172.64M | -125.15%-78.07M | 23.32%-17.9M |
| Other net revenue | 1,590.92%216.91M | 73.48%106.33M | 989.88%84.64M | 190.79%104.31M | -75.13%12.83M | 233.20%61.3M | 45.51%-9.51M | -70.75%35.87M | -59.14%51.59M | -71.69%18.4M |
| Fair value change income | 80,822.80%142.13M | 1,685.34%37.18M | 256.58%503.93K | 132.78%9.39M | 97.33%-176.07K | 158.55%2.08M | 94.60%-321.82K | -1,209.83%-28.63M | -385.42%-6.6M | -153.74%-3.56M |
| Invest income | -572.98%-42.14M | -417.61%-39.57M | -136.48%-790.63K | 70.66%31.12M | -17.88%8.91M | 174.96%12.46M | -30.30%2.17M | -59.13%18.24M | -56.42%10.85M | -71.37%4.53M |
| -Including: Investment income associates | -586.46%-72.89M | -454.74%-39.81M | -255.39%-4.79M | -292.89%-10.04M | -303.11%-10.62M | -475.05%-7.18M | -235.42%-1.35M | -11.37%5.2M | 1,057.82%5.23M | 683.83%1.91M |
| Asset deal income | -89.43%2.46M | 416.96%1.66M | -101.48%-12.51K | 3,762.56%31.43M | 767.93%23.29M | -84.94%321.85K | -10.05%843.5K | -64.28%813.69K | -16.34%2.68M | 42.57%2.14M |
| Other revenue | 24.18%238.43M | 29.14%185.78M | 61.34%75.14M | 1.35%289.71M | 16.07%192M | 57.30%143.85M | 16.61%46.57M | 31.50%285.87M | 3.10%165.41M | 0.32%91.45M |
| Operating profit | -11.87%3.43B | -16.73%2.62B | -7.54%1.66B | 19.23%4.48B | 19.58%3.89B | 25.95%3.15B | 18.76%1.8B | 27.35%3.75B | 34.20%3.25B | 37.68%2.5B |
| Add:Non operating Income | -69.04%33.61M | 0.84%25.97M | -3.71%11.38M | 176.49%141.81M | 299.10%108.55M | 29.16%25.75M | 194.43%11.82M | 44.31%51.29M | 39.27%27.2M | 114.68%19.94M |
| Less:Non operating expense | 165.42%28.64M | 53.15%21.51M | 42.87%9.38M | -53.74%23.23M | -61.15%10.79M | -40.34%14.05M | -18.56%6.56M | 159.85%50.21M | 99.31%27.77M | 158.61%23.55M |
| Total profit | -13.90%3.43B | -16.90%2.63B | -7.70%1.66B | 22.35%4.59B | 22.61%3.98B | 26.60%3.16B | 19.43%1.8B | 26.69%3.75B | 33.86%3.25B | 37.47%2.5B |
| Less:Income tax cost | -28.19%531.31M | -28.91%413.8M | -4.85%333M | 40.43%815.87M | 33.42%739.89M | 33.64%582.11M | 24.82%349.98M | 24.56%580.97M | 23.38%554.54M | 18.79%435.57M |
| Net profit | -10.65%2.9B | -14.18%2.21B | -8.38%1.33B | 19.04%3.78B | 20.39%3.24B | 25.11%2.58B | 18.20%1.45B | 27.09%3.17B | 36.24%2.7B | 42.20%2.06B |
| Net profit from continuing operation | -10.65%2.9B | -14.18%2.21B | -8.38%1.33B | 19.04%3.78B | 20.39%3.24B | 25.11%2.58B | 18.20%1.45B | 27.09%3.17B | 36.24%2.7B | 42.20%2.06B |
| Less:Minority Profit | 91.82%546.47M | 121.79%396.33M | -31.38%61.3M | 27.86%409.85M | -2.63%284.88M | -2.21%178.69M | 13.91%89.34M | 564.91%320.55M | 1,031.76%292.58M | 1,076.61%182.73M |
| Net profit of parent company owners | -20.51%2.35B | -24.31%1.82B | -6.87%1.27B | 18.05%3.37B | 23.19%2.96B | 27.77%2.4B | 18.49%1.36B | 16.50%2.85B | 23.06%2.4B | 30.99%1.88B |
| Earning per share | ||||||||||
| Basic earning per share | -20.22%1.42 | -24.31%1.09 | -6.54%1 | 17.41%2.63 | -5.32%1.78 | -2.04%1.44 | -7.76%1.07 | -9.68%2.24 | -5.53%1.88 | 0.68%1.47 |
| Diluted earning per share | -20.22%1.42 | -24.31%1.09 | -7.48%0.99 | 17.94%2.63 | -5.32%1.78 | -2.04%1.44 | -7.76%1.07 | -10.08%2.23 | -5.53%1.88 | 0.68%1.47 |
| Other composite income | 1,510.25%16.25M | 678.89%172.73K | 1,365.86%1.22M | -113.22%-11.1M | -125.01%-1.15M | -100.41%-29.84K | 97.77%-96.17K | -107.40%-5.21M | -87.37%4.61M | 1,703.99%7.23M |
| Other composite income of parent company owners | 1,497.88%5.9M | 2,794.11%1.25M | 1,515.71%299.63K | -1,316.67%-8.08M | -107.83%-422.07K | -99.37%43.04K | 99.49%-21.16K | -99.06%664.35K | -85.23%5.39M | 1,593.27%6.78M |
| Other composite income of minority owners | 1,517.39%10.35M | -1,372.24%-1.07M | 1,323.58%917.74K | 48.55%-3.02M | 6.56%-730.44K | -116.43%-72.88K | 60.86%-75K | -67,478.48%-5.87M | ---781.74K | --443.47K |
| Total composite income | -10.11%2.92B | -14.17%2.21B | -8.29%1.33B | 18.89%3.77B | 20.14%3.24B | 24.67%2.58B | 18.60%1.45B | 23.40%3.17B | 34.01%2.7B | 42.66%2.07B |
| Total composite income of parent company owners | -20.30%2.36B | -24.26%1.82B | -6.85%1.27B | 17.74%3.36B | 22.90%2.96B | 27.31%2.4B | 18.91%1.36B | 13.27%2.85B | 21.08%2.41B | 31.42%1.88B |
| Total composite income of minority owners | 95.96%556.82M | 121.28%395.26M | -30.30%62.22M | 29.29%406.83M | -2.62%284.15M | -2.49%178.62M | 14.10%89.27M | 552.61%314.67M | 1,028.73%291.8M | 1,079.46%183.18M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Tariff game between the US and Europe shakes the market! Will TACO happen again?
Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren
Futubull Options Sir
Jan 19 17:47
Options Weekly 0119 | Greenland tariff standoff, gold and silver surge again, shocking reversal in Fed chair nominee! Watch Intel, Netflix earnings reports
杨杨得億
Jan 20 13:42
The real danger in the 2026 market isn't black swan events, but rather the changes you've become accustomed to ignoring.